Copyright
©The Author(s) 2025.
World J Hepatol. Feb 27, 2025; 17(2): 101936
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101936
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101936
Table 4 Comparison of biochemical and clinical characteristics between patients with good and poor glycemic control, mean ± SD
Variable | Total (n = 150) | Good control (n = 127) | Poor control (n = 23) | t-test | P value |
TG (mg/dL) | 102.23 ± 75.33 | 97.97 ± 74.56 | 127.61 ± 74.69 | -1.751 | 0.090 |
GGT (U/L) | 42.71 ± 24.66 | 40.60 ± 24.23 | 53.48 ± 25.08 | -2.278 | 0.030 |
HbA1c (%) | 5.15 ± 1.49 | 4.66 ± 0.98 | 7.82 ± 0.85 | -16.036 | < 0.001 |
WC (cm) | 75.96 ± 26.25 | 74.90 ± 25.79 | 80.39 ± 30.12 | -0.822 | 0.418 |
BMI (kg/m2) | 24.49 ± 6.22 | 25.57 ± 18.17 | 27.06 ± 7.64 | -0.659 | 0.512 |
- Citation: Ojong EW, Ngemenya MN, Tafili MM, Tanue EA, Achidi EA. Association of non-alcoholic fatty liver disease with glycemic control among patients with type 2 diabetes mellitus at Limbe Regional Hospital, Southwest, Cameroon. World J Hepatol 2025; 17(2): 101936
- URL: https://www.wjgnet.com/1948-5182/full/v17/i2/101936.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i2.101936